Compound Detail
CHEMBL5289777
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C=C(F)C(=O)N1CCN(c2nc(O[C@@H]3CCCN3CCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)nc3c2CCN(c2cccc4cccc(Cl)c24)C3)C[C@H]1CC#N
Basic Information
| ChEMBL ID | CHEMBL5289777 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FTSNKXXRMZUQSC-AUYKJQTJSA-N |
1
Targets
5
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
1118.8
MW (Da)
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 5 meas. best 6.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| von Hippel-Lindau disease tumor suppressor/KRAS CHEMBL5169273 | EC50 | 6.6 | 6.6 | 250.0 | 5 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36274273 | 10.1016/j.ejmech.2022.114838 | von Hippel-Lindau disease tumor suppressor/KRAS | 5 |
Data from ChEMBL 36 via Core Engine